Copyright
©2009 The WJG Press and Baishideng.
World J Gastroenterol. Jul 28, 2009; 15(28): 3493-3497
Published online Jul 28, 2009. doi: 10.3748/wjg.15.3493
Published online Jul 28, 2009. doi: 10.3748/wjg.15.3493
Haplotype COX-2 | Adenocarcinoma | Squamous cell carcinoma | Controls n = 236 (%) | ||
n= 163 (%) | OR (95% CI) | n= 59 (%) | OR (95% CI) | ||
AG/AG | 59 (36.2) | Reference | 18 (30.5) | Reference | 94 (39.8) |
AG/AC | 29 (17.8) | 0.87 (0.50-1.52) | 12 (20.3) | 1.18 (0.53-2.64) | 53 (22.4) |
AC/AC | 5 (3.1) | 1.33 (0.39-4.55) | 2 (3.4) | 1.74 (0.33-9.32) | 6 (2.5) |
GC/AC | 0 (0) | - | 0 (0) | - | 0 (0) |
GG/AC | 17 (10.4) | 1.29 (0.63-2.64) | 4 (6.8) | 0.99 (0.31-3.24) | 21 (8.9) |
GG/AG | 40 (24.5) | 1.14 (0.68-1.91) | 19 (32.2) | 1.77 (0.86-3.66) | 56 (23.7) |
GG/GG | 13 (8.0) | 3.45 (1.24-9.58) | 4 (6.8) | 3.48 (0.89-13.6) | 6 (2.5) |
-
Citation: Kristinsson JO, Westerveld PV, Morsche RHT, Roelofs HM, Wobbes T, Witteman BJ, Tan AC, Oijen MGV, Jansen JB, Peters WH.
Cyclooxygenase-2 polymorphisms and the risk of esophageal adeno- or squamous cell carcinoma. World J Gastroenterol 2009; 15(28): 3493-3497 - URL: https://www.wjgnet.com/1007-9327/full/v15/i28/3493.htm
- DOI: https://dx.doi.org/10.3748/wjg.15.3493